[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339913-105":59,"doc-detail-339913-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-crosstalk-between-lung-cancer-and-the-bone-marrow-niche-fuels-emergency-myelopoiesis-read-online-free","The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis - read online free","","Advanced lung cancer patients often show modest immunotherapy response rates, driving the need for dependable biomarkers and actionable targets. The article reviews links between effective responses and factors such as PD-L1 expression, tumor mutation burden, and a “hot” tumor microenvironment enriched for effector T cells. In contrast, the predictive value of tumor-infiltrating myeloid cells remains uncertain due to their wide diversity in origin, phenotype, location, and function. The paper summarizes evidence connecting lung cancer progression to emergency myelopoiesis via changes in intra- and extramedullary hematopoiesis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-crosstalk-between-lung-cancer-and-the-bone-marrow-niche-fuels-emergency-myelopoiesis-read-online-free/339913/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-crosstalk-between-lung-cancer-and-the-bone-marrow-niche-fuels-emergency-myelopoiesis-read-online-free/339913.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is identifying biomarkers important for advanced lung cancer immunotherapy?","Question",{"text":112,"@type":113},"Response rates to immunotherapy are modest, so reliable biomarkers and druggable targets are needed to improve treatment decisions and efficacy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which factors are associated with positive immunotherapy responses?",{"text":117,"@type":113},"Positive responses have been linked to PD-L1 expression, tumor mutation burden, and a “hot” tumor microenvironment with increased effector T cell infiltration.",{"name":119,"@type":110,"acceptedAnswer":120},"What makes the role of tumor-infiltrating myeloid cells (TIMs) difficult to predict?",{"text":121,"@type":113},"TIMs show substantial diversity in ontogeny, phenotype, location, and function, which limits clear consensus on their predictive power.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339913,1790196530,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Review  \nPUBLISHED 01 August 2024  \nDOI 10.3389/fimmu.2024.1397469  \nOPEN ACCESS  \nEDITED BY  \nZhihui Zhang,  \nChinese Academy of Medical Sciences and Peking Union Medical College, China  \nREVIEWED BY  \nIsabel Ben-Batalla,  \nGerman Cancer Research Center (DKFZ), Germany  \nXiaoxin Hao,  \nChinese Academy of Medical Sciences, China  \n*CORRESPONDENCE Cleo Goyvaerts  \n [cleo.goyvaerts@vub.be](cleo.goyvaerts@vub.be)  \nRECEIVED 07 March 2024  \nACCEPTED 15 July 2024  \nPUBLISHED 01 August 2024  \nCITATION  \nCalderon-Espinosa E, De Ridder K, Benoot T, Jansen Y, Vanhonacker D, Heestermans R, De Becker A, Van Riet I, Decoster L and  \nGoyvaerts C (2024) The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis.  \nFront. Immunol. 15:1397469 .  \ndoi: 10.3389/fimmu.2024.1397469  \nCOPYRIGHT  \n© 2024 Calderon-Espinosa, De Ridder, Benoot, Jansen, Vanhonacker, Heestermans, De Becker, Van Riet, Decoster and Goyvaerts. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis  \nEvelyn Calderon-Espinosa 1,2,3, Kirsten De Ridder 1,2, Thomas Benoot 1,2, Yanina Jansen 4, Domien Vanhonacker 5, Robbe Heestermans 6, Ann De Becker 6, Ivan Van Riet 6, Lore Decoster 7 and Cleo Goyvaerts 1,2*  \n1 Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center (TORC), Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium, 2 Laboratory for Molecular Imaging and Therapy (MITH), Vrije Universiteit Brussel, Brussels, Belgium, 3 Department of Chemistry, University of Warwick, Warwick, United Kingdom, 4 Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium, 5 Department of Anesthesiology, Perioperative and Pain Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel),  \nBrussels, Belgium, 6 Department of Hematology, Team Hematology and Immunology (HEIM), Translational Oncology Research Center (TORC), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium, 7 Department of Medical Oncology, Team Laboratory for Medical and Molecular Oncology (LMMO), Translational Oncology Research Center (TORC), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium  \nModest response rates to immunotherapy observed in advanced lung cancer patients underscore the need to identify reliable biomarkers and targets, enhancing both treatment decision-making and efﬁcacy. Factors such as PDL1 expression, tumor mutation burden, and a ‘ hot’ tumor microenvironment with heightened effector T cell inﬁltration have consistently been associated with positive responses. In contrast, the predictive role of the abundantly present tumor-inﬁltrating myeloid cell (TIMs) fraction remains somewhat uncertain, partly explained by their towering variety in terms of ontogeny, phenotype, location, and function. Nevertheless, numerous preclinical and clinical studies established a clear link between lung cancer progression and alterations in intraand extramedullary hematopoiesis, leading to emergency myelopoiesis at the expense of megakaryocyte/erythroid and lymphoid differentiation. These observations afﬁrm that a continuous crosstalk between solid cancers such as lung cancer and the bone marrow niche (BMN) must take place. However, the BMN, encompassing hematopoietic stem and progenitor cells, differentiated immune and stromal cells, remains inadequately explored in solid cancer patients. Subsequently, no clea","cbCaisejJlFA675K","https://ap.wps.com/l/cbCaisejJlFA675K","pdf",1310008,"English","# 1 Introduction\n## Lung cancer burden and immunotherapy context\n## NSCLC subtypes and incidence-mortality trends\n## Rationale for biomarker identification","[{\"question\":\"Why is identifying biomarkers important for advanced lung cancer immunotherapy?\",\"answer\":\"Response rates to immunotherapy are modest, so reliable biomarkers and druggable targets are needed to improve treatment decisions and efficacy.\"},{\"question\":\"Which factors are associated with positive immunotherapy responses?\",\"answer\":\"Positive responses have been linked to PD-L1 expression, tumor mutation burden, and a “hot” tumor microenvironment with increased effector T cell infiltration.\"},{\"question\":\"What makes the role of tumor-infiltrating myeloid cells (TIMs) difficult to predict?\",\"answer\":\"TIMs show substantial diversity in ontogeny, phenotype, location, and function, which limits clear consensus on their predictive power.\"}]","The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis - read online free | PDF",1790033047,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92cd10365a97d444d3dd86a0dd4ebc9a.webp",983,1389,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99a9c1b9e68dd13cd100a27206fb19ba.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59ac60596c847c7189e02a0165dda0ae.webp",981,1386,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ccfb17dd7bea3e18156275e4e41759c7.webp",980,1385]